
NHI Stock Forecast & Price Target
NHI Analyst Ratings
Bulls say
National Health Investors Inc. has demonstrated a positive outlook driven by an increase in normalized Funds from Operations (NFFO) estimates, which have been raised to $4.80 per share for 2025, aligning closely with management's guidance range. The company is also projected to achieve a year-over-year growth in normalized FFO per share of 5.3% in 2025 and 4.8% in 2026, reflecting strong operational performance and an encouraging trajectory. Additionally, the company's revenue streams from diverse real estate investments and senior housing operations position it favorably within the market, further enhancing its financial prospects.
Bears say
National Health Investors Inc. faces a negative outlook primarily due to anticipated lower earnings growth over the next few years, which reflects the challenges associated with balancing acquisition activities against operator issues and transitions. The reliance on rental income and the potential for lower-than-expected rent resets, particularly from its NHC segment, further exacerbates financial risks. Additionally, concerns over deferred rent collections and the vulnerability of operators, especially in the context of potential future pandemics or outbreaks, contribute to the adverse financial projections for the company.
This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.
NHI Analyst Forecast & Price Prediction
Start investing in NHI
Order type
Buy in
Order amount
Est. shares
0 shares